Hercules Capital Research and Development Expenses 2010-2023 | HTGC

Hercules Capital research and development expenses from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Hercules Capital Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Hercules Capital Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Finance Finance - SBIC & Commercial $3.227B $0.461B
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
Stock Name Country Market Cap PE Ratio
Ares Capital (ARCC) United States $12.824B 8.83
Blackstone Secured Lending Fund (BXSL) United States $6.085B 8.23
FS KKR Capital (FSK) United States $5.565B 6.49
Main Street Capital (MAIN) United States $4.198B 11.57
Golub Capital BDC (GBDC) United States $2.869B 8.58
Morgan Stanley Direct Lending Fund (MSDL) United States $1.979B 8.34
Goldman Sachs BDC (GSBD) United States $1.785B 6.89
New Mountain Finance (NMFC) United States $1.341B 8.14
BARINGS BDC, INC (BBDC) United States $1.030B 8.03
Nuveen Churchill Direct Lending (NCDL) United States $0.956B 0.00
BLACKROCK TCP CAPITAL CORP (TCPC) United States $0.911B 5.72
Carlyle Secured Lending (CGBD) United States $0.906B 8.33
SLR Investment (SLRC) United States $0.884B 9.42
Amalgamated Financial (AMAL) United States $0.780B 8.44
Trinity Capital (TRIN) United States $0.736B 6.79
Crescent Capital BDC (CCAP) United States $0.674B 7.61
CION Investment (CION) United States $0.652B 6.12
Fidus Investment (FDUS) United States $0.632B 7.88
Palmer Square Capital BDC (PSBD) United States $0.535B 0.00
Gladstone Investment (GAIN) United States $0.522B 14.36
Gladstone Capital (GLAD) United States $0.482B 11.25
PennantPark Investment (PNNT) United States $0.475B 6.93
Runway Growth Finance (RWAY) United States $0.456B 5.96
Horizon Technology Finance (HRZN) United States $0.415B 6.23
TriplePoint Venture Growth BDC (TPVG) United States $0.349B 4.73
Stellus Capital Investment (SCM) United States $0.345B 7.37
Saratoga Investment Corp (SAR) United States $0.317B 5.63
WhiteHorse Finance (WHF) United States $0.296B 6.89
Oxford Square Capital (OXSQ) United States $0.192B 6.71
Medallion Financial (MFIN) United States $0.187B 3.76
OFS Capital (OFS) United States $0.129B 6.21
PhenixFIN (PFX) United States $0.096B 18.05
Advanced Medical Isotope (RDGL) United States $0.078B 0.00
Silver Spike Investment (SSIC) United States $0.070B 13.45
Logan Ridge Finance (LRFC) United States $0.060B 16.03
Investcorp Credit Management BDC (ICMB) United States $0.047B 5.53
Bain Capital Specialty Finance (BCSF) United States $0.000B 7.51
Rand Capital (RAND) United States $0.000B 11.26